Modification of deoxyribose-phosphate residues by extracts of ataxia telangiectasia cells.
The release of DNA 5'-terminal deoxyribose-phosphate residues from enzymatically incised apurinic/apyrimidinic sites by human cell extracts has been under investigation. During the course of these studies, we observed that ataxia telangiectasia cell extracts modify deoxyribose-phosphate (dRp) residues by converting them to an altered form, dRp-X, which shows altered chromatographic properties on HPLC analysis. The chemical nature of the adduct is as yet unknown, but dRp-X is stable to both heat and acid. The modification requires an enzymatic activity and a low-molecular weight co-factor. Extracts of normal cells contain a dialyzable inhibitor that suppresses the reaction occurring with ataxia telangiectasia cell extracts. Formation of dRp-X has been observed in 7 out of 7 ataxia telangiectasia lymphoblastoid lines which represent at least 3 genetic complementation groups. Similar modification of dRp did not occur with extracts of cells of normal origin, nor those representing Fanconi's anaemia, xeroderma pigmentosum, Bloom's syndrome, Werner's syndrome or Friedreich's ataxia.
Karam
L R
LR
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts, Great Britain.
Calsou
P
P
Franklin
W A
WA
Painter
R B
RB
Olsson
M
M
Lindahl
T
T
D001260:Ataxia Telangiectasia / Q000378:metabolism*; D002455:Cell Division; D002460:Cell Line; D004249:DNA Damage; D004260:DNA Repair; D006801:Humans; D010428:Pentosephosphates / Q000378:metabolism*; D012267:Ribosemonophosphates / Q000378:metabolism*; D014020:Tissue Extracts / Q000378:metabolism
D010428:Pentosephosphates; D012267:Ribosemonophosphates; D014020:Tissue Extracts; C058245:2-deoxyribose 5-phosphate